{
  "actions": [
    {
      "acted_at": "2019-07-10", 
      "action_code": "10000", 
      "references": [], 
      "text": "Introduced in Senate", 
      "type": "action"
    }, 
    {
      "acted_at": "2019-07-10", 
      "action_code": "", 
      "committees": [
        "SSHR"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s2074-116", 
  "bill_type": "s", 
  "by_request": false, 
  "committee_reports": [], 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "Senate Health, Education, Labor, and Pensions", 
      "committee_id": "SSHR"
    }
  ], 
  "congress": "116", 
  "cosponsors": [
    {
      "bioguide_id": "M001153", 
      "district": null, 
      "name": "Murkowski, Lisa", 
      "original_cosponsor": true, 
      "sponsored_at": "2019-07-10", 
      "state": "AK", 
      "title": "Sen", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2019-07-10", 
  "number": "2074", 
  "official_title": "A bill to amend section 303(g) of the Controlled Substances Act (21 U.S.C. 823(g)) to eliminate the separate registration requirement for dispensing narcotic drugs in schedule III, IV, or V, such as buprenorphine, for maintenance or detoxification treatment, and for other purposes.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Mainstreaming Addiction Treatment Act of 2019", 
  "sponsor": {
    "bioguide_id": "H001076", 
    "district": null, 
    "name": "Hassan, Margaret Wood", 
    "state": "NH", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2019-07-10", 
  "subjects": [], 
  "subjects_top_term": null, 
  "summary": null, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "A bill to amend section 303(g) of the Controlled Substances Act (21 U.S.C. 823(g)) to eliminate the separate registration requirement for dispensing narcotic drugs in schedule III, IV, or V, such as buprenorphine, for maintenance or detoxification treatment, and for other purposes.", 
      "type": "official"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Mainstreaming Addiction Treatment Act of 2019", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Mainstreaming Addiction Treatment Act of 2019", 
      "type": "short"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "Mainstreaming Addiction Treatment Act of 2019", 
      "type": "display"
    }
  ], 
  "updated_at": "2019-07-20T04:57:30Z", 
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/116/s/BILLSTATUS-116s2074.xml"
}